流动中的喘内型:整合1型和2型炎症以促进生物治疗
Picheswara Rao Polu1, Vamsi Krishna Bikki2
1Research and Development Cell, Department of Intellectual Property Rights, Lovely Professional University, Phagwara, Punjab, India.
概括
了解1型 (T1) 和2型 (T2) 喘内型是精确治疗的关键. 整合T1/T2洞察力可以改善复杂喘病例的生物治疗选择和患者的治疗结果.
科学领域:
- 肺部医学
- 免疫学
- 药理学
背景情况:
- 根据不同的炎症途径,喘被分为1型 (T1) 和2型 (T2) 内型.
- 这种T2炎症涉及IL-4,IL-5,IL-13,以及已确定的生物标志物和向生物药物.
- T1炎症涉及IFN-γ,TNF-α,IL-17和中性粒细胞,缺乏验证的生物标志物和有效的治疗方法.
研究的目的:
- 综合目前关于T1和T2喘内型的知识.
- 评估如何整合T1和T2内型理解可以推进精确的生物治疗选择.
- 改善患者的喘治疗结果.
主要方法:
- 来自PubMed,Embase和Cochrane数据库的同行评审文章的综合文献评论.
- 包括临床试验记录,监管文件和会议记录.
- 根据T1/ T2通路,生物标志物,治疗疗效和内型导向策略进行研究选择.
主要成果:
- 在T2喘中,已验证了生物标志物 (例如FeNO,血红素) 和有效的生物药物 (例如抗IL-5,抗IL-4Rα).
- T1喘缺乏有效的生物标志物和治疗方法.
- 新出现的证据显示T1/T2重叠在严重的喘中,挑战二分法分类;多途径准显示出希望.
结论:
- 通过经过验证的生物标志物和多种组分来整合T1和T2内型特征对于精确的喘医学至关重要.
- 未来的疗法必须针对内型可塑性和混合炎症,以选择最佳的生物疗法.
- 通过先进的内型导向策略,预计在异质喘群体中改善治疗结果.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:19Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461